Three decades of bean seed research & development in sub-Saharan Africa: Key pathways to successful legume seed systems in developing countries
Outlook on Agriculture · 29.09.2026
DOI: 10.1177/00307270261492734 ↗Kurz gefasst
Fachartikel in der Zeitschrift Outlook on Agriculture, online erschienen am 29.09.2026. Verfasst von Jean Claude Rubyogo und 15 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: African Development Bank Group, Bill and Melinda Gates Foundation, Consortium of International Agricultural Research Centers.
Abstract (Originalsprache)
For more than three decades (1996–2026), the Pan-African Bean Research Alliance (PABRA) has worked to improve bean seed systems in sub-Saharan Africa. This review synthesizes PABRA's evolution from localized, largely public-sector, seed-only approaches to scalable, demand-led systems anchored in private-sector-led multi-stakeholder platforms (MSPs). Drawing on 10 country cases—Burundi, Cameroon, Ethiopia, Kenya, Malawi, Rwanda, Tanzania, Uganda, Zambia, and Zimbabwe—the review identifies five linked pathways to success: (1) creating demand-pull by linking seed production to grain markets; (2) fostering institutional pluralism through MSPs; (3) decentralizing demand-led seed production through private-sector engagement and Quality Declared Seed models; (4) integrating demand-led breeding through product profiles; and (5) building resilience through real-time feedback loops. These pathways, operationalized through spatially defined bean corridors that align production, distribution, and consumption hubs, have accelerated variety turnover, increased seed-enterprise investment, and improved genetic gains in farmers’ fields. Between 2015 and 2025, several seed system indicators improved. Off-taker-centered MSPs expanded from none to 76, involving more than 200 traders in 10 countries; bean seed enterprises nearly quadrupled, from 101 to 356; and the average time from variety release to farmer use declined from 15 years to 1–4 years. In targeted countries, the share of new improved varieties—those less than 10 years old—in commercial seed rose from below 17% to 40.9–91%. Annual breeder seed production increased from 50.7 to 159.4 metric tons (MT), foundation seed from 188.2 to 1463.8 MT, and certified seed from 11,291.3 to 18,393.5 MT. These bean seed system models are now being adapted for other legumes and crops, providing a practical blueprint for future seed system development.
Förderung
- African Development Bank Group
- Bill and Melinda Gates Foundation
- Consortium of International Agricultural Research Centers
- Direktion für Entwicklung und Zusammenarbeit
- Global Affairs Canada
Zitieren
APA
Rubyogo, J. C., Aseete, P., Sperling, L., Buruchara, R., Ong’or, D., Ochieng, J., Kalemera, S., Nkhata, W., Mulube, M., Karanja, D., Tsegaye, D., Rurangwa, E., Ndabashinze, B., Mafouasson, A. H. N., Tsekenedza, S., & Paparu, P. (2026). Three decades of bean seed research & development in sub-Saharan Africa: Key pathways to successful legume seed systems in developing countries. Outlook on Agriculture. https://doi.org/10.1177/00307270261492734
Vancouver
Rubyogo JC, Aseete P, Sperling L, Buruchara R, Ong’or D, Ochieng J, et al. Three decades of bean seed research & development in sub-Saharan Africa: Key pathways to successful legume seed systems in developing countries. Outlook on Agriculture. 2026. doi:10.1177/00307270261492734
BibTeX
@article{Rubyogo2026,
author = {Rubyogo, Jean Claude and Aseete, Paul and Sperling, Louise and Buruchara, Robin and Ong’or, Dennis and Ochieng, Justus and Kalemera, Sylvia and Nkhata, Wilson and Mulube, Mwiinga and Karanja, David and Tsegaye, Dagmawit and Rurangwa, Edouard and Ndabashinze, Blaise and Mafouasson, Apala Hortense Noelle and Tsekenedza, Shylet and Paparu, Pamela},
title = {Three decades of bean seed research & development in sub-Saharan Africa: Key pathways to successful legume seed systems in developing countries},
journal = {Outlook on Agriculture},
year = {2026},
doi = {10.1177/00307270261492734}
}
EUVIMED